Drugplain

Cyltezo

adalimumab-adbm · KIT · Boehringer Ingelheim Pharmaceuticals, Inc.

No Recall History
Plain English

Cyltezo is a kit containing adalimumab-adbm. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc..

Key Facts

Brand Name
Cyltezo
Generic Name
adalimumab-adbm
NDC Code (Product)
0597-0405
Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
Dosage Form
KIT
Marketing Status
Application #
BLA761058
Marketing Start
07/01/2023

Recall History

No Recall History

Frequently Asked Questions

What is Cyltezo used for?

Cyltezo contains adalimumab-adbm. It is a kit taken as directed. Consult your doctor for specific uses.

Is Cyltezo a controlled substance?

Cyltezo is not classified as a controlled substance by the DEA.

What is the generic name for Cyltezo?

The generic name for Cyltezo is adalimumab-adbm. There are 9 other brand versions of adalimumab-adbm.

What is the NDC code for Cyltezo ?

The NDC (National Drug Code) for Cyltezo is 0597-0405, listed by Boehringer Ingelheim Pharmaceuticals, Inc..

Product NDC

0597-0405

Package NDC

0597-0405-80

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)